Dr. Yu Feng is an Associate Professor in the School of Chemical Engineering at Oklahoma State University (OSU). He is also a center investigator in the Oklahoma Center for Respiratory and Infectious Diseases (OCRID). Dr. Feng completed his B.S. in Engineering Mechanics at the School of Aeronautics and Astronautics, Zhejiang University, China, in 2007. He pursued further education at the Department of Mechanical and Aerospace Engineering at North Carolina State University, where he obtained his M.S. and Ph.D. degrees in 2010 and 2013, respectively. At OSU, Dr. Feng heads the Computational Biofluidics and Biomechanics Laboratory (CBBL) (www.cbbl-okstate.com), which is dedicated to pioneering research in Computational Fluid Particle Dynamics (CFPD), the Discrete Element Method (DEM), Physiologically Based Pharmacokinetic/Toxicokinetic/Pharmacodynamics (PBPK/TK/PD), and Artificial Intelligence (AI) to drive innovation in pulmonary healthcare and enhance occupational safety.
His research team is focused on delving into the underlying physics and chemistry to develop non-invasive, cost-effective, and accurate numerical tools for various biomedical applications. These applications range from health risk assessment and pulmonary drug efficacy improvement to non-invasive disease diagnosis. Dr. Feng’s contributions to in silico pulmonary healthcare and occupational risk assessment have been recognized with the 2022 Journal of Aerosol Science Excellence in Research Award (JASER). He actively contributes to the field as the academic co-chair of the Pharmaceutical Strategy Task Force in the Avicenna Alliance and as a member of The American Association for Aerosol Research (AAAR) development committee. He is also deeply committed to educational efforts, offering modeling courses and outreach programs aimed at K-12 and undergraduate students to deepen their understanding of biomedical engineering and the application of in silico tools to address pulmonary healthcare challenges.
